Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Raw Materials: 2021-2024

Historic Raw Materials for Organogenesis Holdings (ORGO) over the last 4 years, with Dec 2024 value amounting to $13.3 million.

  • Organogenesis Holdings' Raw Materials rose 8.29% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 8.29%. This contributed to the annual value of $13.3 million for FY2024, which is 2.03% up from last year.
  • As of FY2024, Organogenesis Holdings' Raw Materials stood at $13.3 million, which was up 2.03% from $13.0 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Raw Materials registered a high of $13.3 million during FY2024, and its lowest value of $9.0 million during FY2021.
  • In the last 3 years, Organogenesis Holdings' Raw Materials had a median value of $13.0 million in 2023 and averaged $12.8 million.
  • Data for Organogenesis Holdings' Raw Materials shows a peak YoY surged of 36.12% (in 2022) over the last 5 years.
  • Organogenesis Holdings' Raw Materials (Yearly) stood at $9.0 million in 2021, then surged by 36.12% to $12.3 million in 2022, then increased by 5.75% to $13.0 million in 2023, then grew by 2.03% to $13.3 million in 2024.